Bile duct cancer, also known as cholangiocarcinoma (CCA), is a rare cancer often diagnosed only at an advanced stage. A comprehensive analysis of diagnostic, prognostic, and therapeutic aspects of over 2,200 patients in Europe ...
Feb 14, 2022
0
7
Bile duct cancers are amongst the most aggressive tumour-related diseases and, so far, the medical treatment options available have been limited. Clinical oncologists at the Comprehensive Cancer Center at the MedUni Vienna ...
Jan 13, 2015
0
6
Bile duct cancer is a rare but aggressive form of cancer, affecting just over 2,000 people in the UK every year. However, incidences of bile cancer are steadily increasing every year—with some estimating it could one day ...
Jun 9, 2021
0
2
Researchers at the Translational Genomics Research Institute (TGen) and physicians at Mayo Clinic's Individualized Medicine Clinic have personalized drug treatments for patients with cholangiocarcinoma using genomic sequencing ...
Feb 14, 2014
0
0
The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) are studying the safety and effectiveness of a new drug, AG-120, for treatment of patients with solid tumors, ...
Jun 17, 2014
0
1
Imagine how much patients could benefit if you could discover the presence of cancer, and even how that cancer develops over time, with a simple blood test.
May 10, 2018
0
6
Experts at the University of Birmingham are working with counterparts at the University of Bristol and in Thailand to identify new ways of detecting and treating a form of bile duct cancer that is claiming more and more lives ...
Mar 9, 2016
0
7
Bile duct cancer is rare and is usually detected too late. Often only extensive liver surgery can help or, in rare cases, liver transplantation. But which patients will benefit from surgery and which will not, because their ...
Aug 31, 2015
0
7
In a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center, the combination of dabrafenib, a BRAF inhibitor, and trametinib, a MEK inhibitor, achieved a 51% overall response rate (ORR) in ...
Aug 18, 2020
0
1
Researchers have discovered that cholangiocarcinoma (CCA), a form of liver cancer also known as bile duct cancer, consists of several molecular subtypes with distinct potential therapies and prognoses.
Dec 13, 2017
0
5
